FDA Adverse Event Injury Summary report: N

INFUSE BONE GRAFT

MDR report key: 2946282 · Received February 6, 2013

Report

Report Number
1030489-2013-00394
Event Type
Injury
Date Received
February 6, 2013
Report Date
January 7, 2013
Manufacturer
MEDTRONIC SOFAMOR DANEK USA, INC
Product Code
NEK
PMA / PMN Number
P000058
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

(B)(6). (B)(4). NEITHER THE DEVICE NOR FILMS OF APPLICABLE IMAGING STUDIES WERE RETURNED TO THE MANUFACTURER FOR EVALUATION. THEREFORE, WE ARE UNABLE TO DETERMINE THE DEFINITIVE CAUSE OF THE REPORTED EVENT. PRODUCTS FROM MULTIPLE MANUFACTURERS WERE IMPLANTED DURING THE PROCEDURE. ALTHOUGH IT IS UNKNOWN IF ANY OF THE DEVICES CONTRIBUTED TO THE REPORTED EVENT, WE ARE FILING THIS MDR FOR NOTIFICATION PURPOSES.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT PRESENTED WITH SPONDYLOLYSIS AT L5-S1. THE PATIENT UNDERWENT LAMINECTOMY, FACETECTOMY, AND DISCECTOMY AT L5-S1 ON THE LEFT, TRANSFORAMINAL LUMBAR INTERBODY FUSION WITH INTERBODY IMPLANT AND RHBMP-2/ACS AT L4-S1, AND PEDICLE SCREW FIXATION AT L5-S1, WITH IN SITU AUTOGRAFT L5-S1 INTERSPACE. 175 DAYS POST-OP, THE PATIENT PRESENTED STATUS POST FUSION, L5-S1 AND WITH BONY OVERGROWTH WITH S1 NERVE ROOT COMPRESSION. THE PATIENT UNDERWENT LAMINECTOMY AND DECOMPRESSION OF S1 ROOT AND L5 ROOT ON THE LEFT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
50812 INFUSE BONE GRAFT FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET NEK MEDTRONIC SOFAMOR DANEK USA, INC M114001AAC

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention